The secondary end points were as follows : non-inferiority of ( 1 ) reduction of Korean health assessment questionnaire ( KHAQ ) score ; ( 2 ) decreased duration of morning stiffness ; and ( 3 ) decrease in the frequency and total dose of rescue drugs after 6 weeks of treatment .